Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor
A technology of ursolic acid and inhibitor, which is applied in the field of medical use of ursolic acid-NF-kappaB inhibitor, can solve the problems of inability to clinically apply, no drug has been found, etc., and achieves small molecular size, reduced rejection, and structural stable effect
Inactive Publication Date: 2011-10-05
TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
View PDF1 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0004] At present, tens of thousands of research reports around the world have verified the importance of this molecular signal and the therapeutic effect that can be achieved after blocking it, bu
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Login to View More
PUM
Login to View More
Abstract
The invention provides medical application of an ursolic acid-NF (Nuclear Factor)-kappaB inhibitor and relates to application of an NF-kappaB inhibitor as an immunomodifier in the field of medicine and scientific research. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used for preparing immunity inhibitor medicines and used in aspects of treating rejection after reducing transplantation and inducing and maintaining transplantation tolerance. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used as antiinflammatory drugs and used for treating multiple chronic inflammatory diseases. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used for preparing ischemia reperfusion injury protective agents and used for treating ischemia reperfusion injury diseases. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used for preparing drugs for preventing and treating endotoxemia and septicopyemia and used for preventing and treating the endotoxemia and the septicopyemia.
Description
technical field [0001] The present invention relates to the application of an NF-kappaB inhibitor as an immunomodulator in the field of medicine and scientific research, especially in anti-transplant rejection, anti-autoimmune disease, anti-ischemia-reperfusion injury, anti-chronic inflammatory response, and anti-endotoxemia and other uses. Background technique [0002] Before the present invention was proposed, medical experts in the field knew very well that the inhibitory regulation of the immune system of the body is the key to the treatment of various diseases, such as the treatment of rejection after organ transplantation, autoimmune diseases, chronic inflammatory diseases, ischemia, etc. reperfusion injury, etc. The regulation of the immune system can start from many aspects, and the innate immune response, as a hot spot in recent research, is an excellent direction to achieve immunosuppression. [0003] The body's immune response is divided into innate immunity and...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): C07J63/00A61K31/56A61P37/06A61P29/00A61P37/02A61P9/10A61P39/02A61P35/00A61P3/10
Inventor 周平刘勇薛承彪
Owner TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com